About Us
The JaPAN consortium was initiated in 2009 by the researchers who are specialized in cancer epidemiology, bioinformatics, and gastroenterology. To date, DNA samples and lifestyle information from over 1300 pancreatic cancer patients and 1000 control subjects have been collected in multiple institutes. One major goal is to elucidate the role of inherited genetic variations in pancreatic cancer susceptibility on the basis of genome-wide association study (GWAS). To identify novel risk loci for pancreatic cancer, the JaPAN consortium conducted its own GWAS, followed by a meta-analysis of other two existing GWASs in the Japanese population (the National Cancer Center (NCC) GWAS and the BioBank Japan (BBJ) GWAS), totaling 2039 cases and 32592 control subjects, which is the largest dataset for pancreatic cancer in the Japanese population.
Founder
- Shogo Kikuchi
Aichi Medical University
Steering Committee
- Yingsong Lin
Aichi Medical University - Masahiro Nakatochi
Nagoya University - Keitaro Matsuo
Aichi Cancer Center Research Institute - Issei Imoto
Aichi Cancer Center Research Institute - Shogo Kikuchi
Aichi Medical University
Current research focus
- Functional characterization of the GP2 gene
- Mendelian randomization (MR) analysis of the relationship between obesity, diabetes and pancreatic cancer
- Individualized prevention and treatment
Affiliated researchers
- Hidemi Ito
Aichi Cancer Center Research Institute - Yasuyuki Hosono
Aichi Cancer Center Research Institute - Issei Imoto
Aichi Cancer Center Research Institute - Akihito Inoko
Aichi Medical University - Hiroshi Ishii
Chiba Cancer Center - Naoki Sasahira
The Cancer Institute Hospital of Japanese Foundation for Cancer Research - Makoto Ueno
Kanagawa Cancer Center - Naoto Egawa
Tokyo Metropolitan Hiroo Hospital - Mitsuru Mori
Hokkaido Chitose College of Rehabilitation - Haruhisa Nakao
Aichi Medical University - Yasushi Adachi
Sapporo Shirakabadai Hospital - Tatsuo Miyamoto
Hiroshima University
Logistics
- Keiko Hanai
Aichi Medical University